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Abstract
Background: Bidens bipinnata are widely distributed in China, which have been widely used as a traditional
Chinese medicine. The aim of this study was to examine the effect of total avonoids of Bidens pilosa L. (TFB) on
adjuvant arthritis (AA) and its possible mechanisms.
Methods: The macroscopic scoring of paw edema, secondary paw swelling, and polyarthritis index were measured.
Histological examination of the joints and the serum concentrations of IL-6, IL-1beta, and TNF-alpha were
examined. Apoptosis in synovial tissue was detected. The expression of Caspase 3 cleavage, serves as a marker
undergoing apoptosis, was confirmed by Western blot.
Results: TFB attenuated the severity of arthritis on paw edema, hind paw volume, and polyarthritis index of AA rats,
improved the histological status in AA rats as well. TFB can inhibit the production of IL-6, IL-1beta, and TNF-alpha
from serum. Clear DNA ladder formation was observed in DNA extraction of synovium from TFB treated AA rats.
The number of apoptosis was increased with TFB treatment in TUNEL assay. TFB treatment on AA rats significantly
increased the expression of Caspase 3 in synovium.
Conclusions: Our data suggest that TFB has a signicant anti-arthritic effect in AA through the induction of
apoptosis in synovial.
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Background
Rheumatoid arthritis (RA) is a chronic, systemic inflam-
matory disorder characterized by polyarthritis with pro-
gressive joint damage and disability, immunologic
abnormalities, systemic inflammation, increased comor-
bidity, and premature mortality [1, 2]. It causes prema-
ture mortality, disability, and reduced quality of life in
“developed” and “developing” countries [3]. The exact
etiology of RA is not known, but infectious agents, oral
contraceptives, smoking and genetic factors are believed
to be responsible for the development of RA [4, 5].
Current therapeutic strategies in RA are focused on
alleviation of the inflammatory reaction, joint pain
and damage. Treatments include non-steroidal anti-
inflammatory drugs (NSAIDs), glucocorticoids, specific
inhibitors of pro-inflammatory mediators, non-biologic
disease-modifying anti-rheumatic drugs (DMARDs) and
biologic DMARDs [6]. However, most of these agents
produce notable adverse effects, and searching for
new agents with safe and effective therapy of RA has
become essential [7–9].
Apoptosis is considered to be one of the mechanisms
regulating autoimmune diseases such as RA [10–12]. It is
well known that increased proliferation and insufficient
apoptosis might contribute to the expansion of fibroblast-
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like synoviocytes (FLSs) in the pathogenesis of RA [13,
14]. Activated FLSs result in: synovium growth along with
angiogenesis in articular cartilage; invasion into adjacent
bone; stimulation of production of pro-inflammatory cyto-
kines; destruction of cartilage and bone [15]. It has been
shown that the induction of apoptosis in the synovium
might be useful for the treatment of RA [16, 17].
The genus Bidens (Asteraceae), a medicinal plant used
worldwide, has been traditionally used for the treatment
hepatitis, inflammation, malaria, hypertension, diabetes,
peptic ulcer, snake bite and smallpox [18, 19]. Bidens
bipinnata L., commonly known as po-po-zhen (pinyin,
China) in China, has also been applied in the treatment
of jaundice, rheumatism, laryngitis, headache and digest-
ive disorders [19, 20]. Pharmacological studies have
shown that the extract of Bidens pilosa L. possess a wide
range of biological activities, including antimalarial [21],
antidiabetic [22], antioxidative [23], anticancer [24], anti-
inflammatory [25], and immunomodulatory activity [26,
27]. Moreover, our previous study demonstrated that the
total extracted flavonoids from Bidens bipinnata L.
(TFB) had anti-inflammatory and antioxidant activity in
acute liver injury [18] and liver fibrosis [19]. Futhermore,
TFB is reported to inhibit the growth of mouse cervical
carcinoma in U14 cells [28]. TFB has attracted much
interest due to its proven pharmacologic safety and its
many anti-inflammatory activities through inhibiting the
production of pro-inflammatory cytokines such as inter-
leukin (IL)-8, tumour necrosis factor (TNF)-a and nitric
oxide (NO) levels in human umbilical vein endothelial
cells [29]. RA is an inflammatory condition that affects
joints primarily leading to pain and stiffness and diffi-
culty in movements [30]. However, it has not been deter-
mined whether TFB is useful for inhibiting inflammation
in RA. The resent study was designed to evaluate the
therapeutic effect of TFB on RA in a rat model of




Male Sprague–Dawley (SD) rats (180–200 g) were pur-
chased from the Shanghai BK Experimental Animal
Center (Shanghai, China). Rats were housed at 21 ± 2 °C
and given free access to standard laboratory rat food pel-
lets and water. Animals were distributed randomly to
each treatment group of eight rats. Group size was de-
termined as the minimum number of rats for valid stat-
istical analyses. Animals were housed in a specific
pathogen-free environment with free access to drinking
water that was supplemented with gentamicin sulfate.
Experiments were conducted according to the guidelines
of the Institutional Animal Care and Use Committee of
the Chinese Association for Laboratory Animal Sciences.
Ethics statement
This study was carried out in strict accordance with the
recommendations in the guidelines of the Institutional
Animal Care and Use Committee of the Chinese Associ-
ation for Laboratory Animal Sciences (approval number
2014AH-08-01). All experimental procedures involving
animals were conducted as per institutional animal care
guidelines of Nantong University and were approved
ethically by the Jiangsu administration committee for ex-
perimental animals, China. All surgery was performed
under diethyl ether, and all efforts were made to
minimize suffering.
Preparation of TFB
The dried aerial parts of Bidens bipinnata L. were col-
lected from a local market and cut into small pieces. A
voucher specimen (Chen 6128333) was deposited in the
College of Pharmacy, Anhui Medical University. Profes-
sor Fan-Rong Wu confirmed the identity of each crude
herb. The dried parts of Bidens pilosa L were extracted
three times with 80 % ethanol at a tempareture of 80 °C
for 2 h and filtered. The filtrates were concentrated in
vacuo to give a syrup, followed by suspension water.
Then, it was dissolved in water and filtered. The liquid
was collected and passed through a column packed with
HPD-100 resin. Elution was done using distilled water,
30 % ethanol, 50 % ethanol and 95 % ethanol. The 30 %
ethanol-eluted solution was concentrated in vacuo to
give TFB from the dried parts of Bidens bipinnata L.
HPLC analysis
The preparation of the individual flavonoids were ana-
lyzed with the HP 1200 Agilent system (Agilent Tech-
nologies, Palo Alto, CA, USA) equipped with a dual
pump, an auto-sampler and a PDA detector. Briefly, fla-
vonoids were analyzed with an Agilent 1200 liquid chro-
matographic system (Agilent Technologies, Santa Clara,
CA, USA) with an analytical column (250 mm × 4.6 mm
I.D., SHIMADZU, Tokyo, Japan). The mobile phase
consisted of 100 % acetonitrile (A) and water containing
0.5 % acetic acid (B) at a flow rate of 0.8 mL/min. The
column temperature was set at 25 °C. The UV diode
array detector was set at 280 nm and sample injection
volume was 5 μl. Several standard compounds including
hyperoside, rutin, maritimetin, quercetin, okanin, isooka-
nin, protocatechuic acid, protocatechuic aldehyde, cat-
echin, isoquercitrin, 7-O-(4”,6”-diacetyl)-b-d-glucopyra
noside, (Z)-6-O-(3,6-di-O-acetyl-d-glucopyranosyl)-6,7,3
’,4’-tetrahydroxyaurone, astragalin, and 2’,4’,6’-trimethoxy-
4-O-d-glucopyranosyl-dihydrochalcone were run for
comparative detection and were optimized. The calibra-
tion curves were defined for each compound in the
range of sample quantity 0.02–0.5 μg. All samples were
assayed in triplicate.
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Acute oral toxicity study
Healthy male Sprague–Dawley rats were subjected to
acute toxicity studies as per Organization for Economic
Co-operation and Development (OECD). The animals
were fasted overnight and divided into group of 6 animals.
The doses of 10, 50, 100, 150, 200, and 250 (mg/kg) were
administered orally once a day for 14 days. Rats were
weighed on days 2, 6, 10, and 14. Total food intake was
measured as the weight of food consumed on days 2, 6,
10, and 14. Clinical signs and conditions associated with
convulsion, ataxia, diarrhea, and impending death of ani-
mals were observed first 6 h and followed by 12 h after
the administration and the animals in both control treated
and TFB-treated groups were conducted daily during the
period. On the 14rd day, rats were anesthetized and sacri-
ficed. Tissues samples from the liver, spleen, lung, kidney,
and brain were collected and embedded in paraffin for
hematoxylin & eosin (H&E) staining.
Creation and evaluation of the model of AA in rats
Creation of a model of AA was as described previously
[31]. Rats were randomly divided by six groups (N = 8/
group): Group a, normal control; Group b, AA; Group c,
TFB 40 mg/kg + AA; Group d; TFB 80 mg/kg + AA;
Group e; TFB 160 mg/kg + AA; and Group f, Glucoside
tripterygium total (GTT, 10 mg/kg) + AA [32, 33]. Rats
were immunized on day-0 by intradermal injection of a
0.1-mL aliquot of complete Freund’s adjuvant (CFA)
containing 10 mg heat-inactivated bacillus Calmette-
Guérin with paraffin oil into the left hind paw. The same
volume of paraffin oil was injected into the left hind paw
as a sham control. CFA-induced arthritis, assessed by
the first signs of visible redness or swelling of the joints,
was observed ≈ 10 days after each immunization in all
groups (eight rats per group). Ten days to 24 days after
CFA administration, rats receiving different doses of
TFB (40, 80 and 160 mg/kg) were given TFB via gastric
gavage. GTT; 10 mg/kg was used as a positive control.
The volume of secondary paw swelling was measured
with a plethysmometer (YLS-7A, Shandong, China). Sec-
ondary paw swelling due to edema was observed as an
increase in the right hind paw by subtracting the paw
volume at day-0 from that at days 10, 13, 17, 21 and 24,
respectively. Moreover, the polyarthritis index of AA was
measured as described previously [34].
Histological processing and analyses of joints
After 28 days, rats were killed for histopathologic exami-
nations. Thereafter, hind limbswere dissected, fixed with
10% phosphate-buffered formalin for 2 days, decalcified
with 10% ethylenediamine tetraacetic acid for 7 days,
and embedded in paraffin. Sections were prepared and
stained with H&E and safranin-O staining for histologic
processing and representative photographs taken.
Measurement of serum concentrations of interleukin (IL)-
6, IL-1β, and TNF-α
Animals were killed on day 28 after AA induction.
Serum samples were collected and stored in −20 °C until
analysis. Serum levels of IL-6, IL-1β and TNF-α were
determined by enzyme-linked immunosorbent assay
(ELISA) kits according to manufacturer instructions
(Dakewe Biotic, Beijing, China).
Detection of DNA ladders
The synovial tissues of the secondary paw swelling of
rats were taken under the sterile condition. Fragmented
DNA was isolated using a DNA Extraction kit (Sangon,
Shanghai, China) according to manufacturer instruc-
tions. DNA extracts were electrophoresed on 1.5 % agar-
ose gel containing ethidium bromide at 50 V/cm for 150
min. Ladder formation of oligonucleosomal DNA was
detected under ultraviolet light.
TUNEL assay
The TUNEL assay was carried out using an In Situ
Apoptosis Detection kit (KeyGEN Biotech, Nanjing,
China) according to manufacturer protocols. Sections
were incubated with Labeling Safe Buffer containing
TdT Enzyme and Biotin-conjugated dUTP at 37 °C for
60 min. Tissue sections were stained with FITC-
conjugated extravidin and then counterstained with
methyl green. To estimate apoptotic cell death, TUNEL-
positive cell density was calculated as number of apop-
totic cells per square millimeter of section.
Western blot analysis
Aliquots (100 mg) of synovial tissues were homogenized
and treated with RIPA Lysis Buffer. Protein concentra-
tion in lysates was measured using a BCA-200 Protein
Assay kit (Pierce, Rockford, IL, USA). An equal amount
(30 μg) of protein was separated by 12% SDS-PAGE and
then transferred by electrophoresis. The primary
antibody of caspase 3 (1:1000 dilution; Santa Cruz Bio-
technology, Santa Cruz, CA, USA) was used for im-
munoblotting. Membranes were washed in Tris-buffered
saline with Tween 20 (TBST), then incubated with sec-
ondary antibody (1:1000 dilution; Santa Cruz Biotech-
nology). The relative intensities of protein bands were
quantified using densitometry (Gel Logic 2200; Care-
stream Health, Rochester, NY, USA).
Statistical analyses
Data are the mean ± standard error of the mean. Statistical
analyses were carried out using SPSS v11.0 (SPSS, license
number:3605877, Chicago, IL, USA). The normality of
distributions was tested. Statistical analyses were under-
taken with one-way analysis of variance followed by a least
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significant difference post hoc test and unpaired Student’s
t-test. P < 0.05 was considered significant.
Results
HPLC qualitative analysis
The flavonoid composition of Bidens bipinnata L. was
detected through HPLC analysis. HPLC analysis of
Bidens bipinnata L. revealed the presence of chromato-
graphic peaks consistent with the pattern showed by the
standards such as catechin, hyperin, isoquercitrin, astra-
galin and quercetin. Quantitative HPLC analysis showed
that hyperin (peak area, 17.855%) and astragalin (peak
area, 13.648%) were the main flavonoids in Bidens bipin-
nata L. (Table 1; Fig. 1).
Acute oral toxicity of TFB in rats
The safety of TFB was evaluated in rats after oral admin-
istration of 10, 50, 100, 150, 200, and 250 (mg/kg) once
a day for 14 days. Body weight, food consumption, and
locomotor activities were performed. As shown in Fig. 2a,
b and c. No significant difference was found in body
weight, mean daily food consumption, and locomotor
activity. Moreover, No significant microscopic lesions
were observed in the liver, spleen, lung, kidney, and
brain histopathology in rats treated with TFB 250 (mg/kg)
(Fig. 2d) as well as gross observation of systemic organs
(Fig. 2e). The doses of 10–250 mg/kg of TFB did not ex-
hibit any mortality or associated symptoms, such as con-
vulsion, ataxia, and diarrhea (Table 2). These indicated
that TFB had low toxicity profile.
TFB inhibited paw volume and the polyarthritis index in
AA rats
The preventive effect of TFB on AA rats was studied by
evaluating the paw volume and the polyarthritis index of
normal and drug-treated AA rats. TFB (40, 80 and 160
mg/kg, p.o.) was given to rats 10 days to 24 days after
CFA administration. Macroscopic evaluation of paw
edema in AA rats showed that paw edema to be induced
in all experimental animals (Fig. 3a). Oral administration
of TFB suppressed hindpaw edema. Inflammatory
polyarthritis was induced in all immunized rats. The sec-
ondary inflammatory reaction appeared at ≈ day-10.
Therefore, therapeutic administration of TFB (40, 80
and 160 mg/kg) was given at that time. CFA injection re-
sulted in progressive swelling of the injected hind paw
Table 1 Flavonoids profile of Bidens bipinnata L. through HPLC
studies
Compound Retention time (min) Peak area(%)
Catechin 11.073 4.145 ± 0.671
Hyperin 23.553 17.855 ± 0.972
Isoquercitrin 24.710 2.674 ± 0.543
Astragalin 33.503 13.648 ± 0.754
Quercetin 56.800 3.818 ± 0.437
Fig. 1 Bidens bipinnata L. picture and HPLC chromatograms of major flavonoids of Bidens bipinnata L. a Bidens bipinnata L. picture. b HPLC of
flavonoids profile of Bidens bipinnata L.: (1) catechin; (2) hyperin; (3) isoquercitrin; (4) astragalin; (5) quercetin
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that increased over time up to day 24. Administration
of TFB (40, 80 and 160 mg/kg) and GTT apparently
decreased the paw volume and polyarthritis index in
AA rats compared with arthritic control rats, and the
efficacy was similar to that of GTT at 10 mg/kg
(Fig. 3b and c).
Effect of TFB on histologic changes in joints of AA rats
Histologic analyses of experimental groups are illus-
trated in Fig. 4a. The characteristic features of synovial
hyperplasia and inflammatory infiltration were observed
in tissues from arthritic rats. After treatment with TFB
for 8 days, synovial proliferation and infiltration of in-
flammatory cells in the synovium tissue were alleviated.
Next, we examined the extent of cartilage damage in the
joints of AA rats employing safranin-O staining (Fig. 4b).
The joints of AA rats showed cartilage destruction, it
was reduced significantly in the AA rats treated with
TFB.
Effect of TFB administration on concentrations of IL-1β,
TNF-α, and IL-6 in the serum of AA rats
At the end of the experiment, we measured the concen-
trations of IL-1β, TNF-α, and IL-6 in rat serum. These
inflammatory cytokines are involved in RA. We exam-
ined the effect of TFB on the production of IL-1β, TNF-
α, and IL-6 using ELISA. Levels of these inflammatory
cytokines in serum induced by CFA were decreased sig-
nificantly in TFB-treated groups compared with the
model group (Fig. 5).
Pro-apoptotic effects of TFB in vivo on synovial apoptosis
in AA rats
To ascertain if TFB induces synovial apoptosis, the
TUNEL assay, detection of DNA ladders, and western
blot analyses were carried out. Analyses of synovial-cell
sections by the TUNEL assay clearly showed extensive
apoptosis in AA rats treated with TFB (Fig. 6a). The
number of TUNEL-positive cells was increased signifi-
cantly in TFB (40, 80 and 160 mg/kg) treatment groups
compared with the AA group (Fig. 6b). Agarose gel elec-
trophoresis showed DNA ladders to be clearly embedded
in TFB (40, 80 and 160 mg/kg) or GTT (10 mg/kg)
(Fig. 6c). Caspase 3 (a typical “execution” caspase in
apoptosis) was clearly activated by TFB because cleavage
Fig. 2 Toxicology evaluation of TFB. a and (b) Effect of TFB on body weight and food intake. Rats were treated with the indicated concentrations
of TFB orally administered once a day for 14 days and body weights were measured with the indicated days. Rat total food intake was
determined as the weight of food consumed during a 24-h period on days 2, 6, 10, and 14. c Locomotor activities of rats. The individual total
running distance of rats was measured during a test period of 30 min on days 12, 6, 10, and 14. d HE staining of rat tissues after daily treatment
with 0 or TFB at 250 mg/kg for 14 days. Scale bars indicate 50 μm. e Gross observation of systemic organs: liver, kidney, lung, heart and spleen
from control and TFB treated rats
Table 2 Clinical signs for control and treated groups
Observation Control group Test group
6 h 12 h 6 h 12 h
Convulsion No No No No
Ataxia No No No No
Diarrhea No No No No
Death 0/6* 0/6a
aNumber of dead rat/ number of rat used
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of caspase 3 was distinctly evident in TFB treatment
groups (Fig. 6d).
Discussion
RA is a common systemic autoimmune disease, which is
characterized by pain and joint swelling, deformity, joint
stiffness and serious functional damage. AA induced by
FCA could act as an experimental model of RA in our
study to demonstrate the effects of TFB on AA rats be-
cause of its similarity to human RA in both clinical and
histopathologic features [35]. Interestingly, our results
suggest that TFB significantly reduces AA severity and
affects the contributory factors of arthritic inflammation
(including production of inflammatory cytokines), which
suggests that TFB is effective in the treatment of AA.
The mechanisms of TFB treatment are related to in-
creases in the apoptosis of synovial cells by regulation of
activation of caspase 3.
It is well known that HPLC is gaining increasing
importance for the analysis of plant extracts [36, 37].
The chemical analysis of total extracted flavonoids
from Bidens bipinnata L. showed that hyperin and
Fig. 3 Pharmacological effects of TFB on CFA-induced arthritis in rats. a Photographic analyses of CFA-induced arthritis in rats. (a): Paw in a normal
control; (b): Paw in AA control rat; (c): Paw in TFB (40 mg/kg)-treated AA rat; (d): Paw in TFB (80 mg/kg)-treated AA rat; (e): Paw in TFB (160 mg/
kg)-treated AA rat; (f): Paw in GTT (10 mg/kg)-treated AA rat. b Effect of TFB on paw swelling (change in volume in mL) in rats with AA. c Effect of
TFB on polyarthritis index in rats with AA. ##p < 0.01 vs normal group; *p < 0.05, **p < 0.01 vs AA group
Fig. 4 Histological assessment of arthritis in AA. Histological sections of ankle joints stained with (a) H&E (A, synovial inflammation, ×200) and (b)
safranin-O (C, cartilage damage, ×200) were examined
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astragalin were the main flavonoids after following
quantitative HPLC analysis. During the acute assess-
ment of the TFB, there was no mortality and no
other severe symptoms were observed up to the dose
of 250 mg/kg in rat.
After FCA administration to rats, development of
arthritis is observed by paw edema owing to soft-tissue
swelling around ankle joints. Infiltration of polymorpho-
nuclear leukocytes and lymphocytes from blood into
joints is a key feature in human and experimental arth-
ritis [38]. In our study, rats injected with CFA exhibited
paw edema in arthritic rats, which might be concomitant
with infiltration of leukocytes into joints [39]. An obvi-
ous reduction of paw swelling and the arthritis index ob-
served in TFB-administered rats could be ascribed to
the effects of TFB.
The inflamed joints of RA patients exhibit infiltration
of inflammatory cells and hyperplasia, which is respon-
sible for the degradation of cartilage and bone. Accord-
ing to the analyses of the histopathologic features of
Fig. 5 Effect of TFB administration on concentrations of IL-1β, TNF-α,
and IL-6 in the sera of AA rats. Data are the mean ± SD, n = 8 per
group. ##p < 0.01 vs normal group; *p < 0.05, **p < 0.01 vs AA group
Fig. 6 Effect of TFB on synovial apoptosis in the ankle joints of rats with AA. a Typical photographs of synovial-cell apoptosis from different
groups. (a) Normal; (b) AA; (c) TFB (40 mg/kg); (d) TFB (80 mg/kg); (e) TFB (160 mg/kg); (f) GTT (10 mg/kg). b Quantitative evaluation of
TUNEL-positive cells. Data are the mean ± SEM (n = 12). *p < 0.05, **p < 0.01 compared with the AA group. c Formation of DNA ladder patterns of
synovial tissues in joints upon TFB treatment. (M) marker; (a) Normal; (b) AA; (c) TFB (40 mg/kg); (d) TFB (80 mg/kg); (e) TFB (160 mg/kg); (f) GTT
(10 mg/kg). d Effects of TFB on expression of caspase-3 protein in synovial tissues from the ankle joints of AA rats
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joints, we determined hyperplasia of the synovial mem-
branes to be a key factor contributing to damage to
joints and tissues in RA [40]. TFB could alleviate prolif-
eration of the synovium, infiltration of inflammatory
cells, and erosion of cartilage in arthritic rats and signifi-
cantly relieve the swelling of ankles, which suggested
that TFB possessed anti-inflammatory effects.
Pro-inflammatory mediators such as TNF-α, IL-1β and
IL-6 have been reported to be responsible for the patho-
genesis of RA based on their contribution to disease
progression at different levels [41]. Therefore, they have
been considered to be crucial cytokines in the pathogen-
esis of RA based on the marked clinical efficacy of anti-
cytokine therapy [42, 43]. Previous study found that in-
creased levels of IL-1β in the early phase of RA and in
the synovial fluid of established RA patients [44, 45].
The importance of IL-1β in onset arthritis is further
highlighted by reports of its ability to promote the differ-
entiation of Th17 cells [46]. Recently, expression of
TNF-α, IL-1β and IL-6 in AA rats has been examined by
ELISA. We also demonstrated elevation of expression of
TNF-α, IL-1β and IL-6 and the inhibitory effect from
TFB in this model.
Research has confirmed that relatively insufficient
apoptosis of synoviocytes in RA causes higher cellular
proliferation and continuous synovial hyperplasia, lead-
ing to the destruction of cartilage and bone [16, 47].
Therefore, induction of synovial apoptosis is proposed to
be one of the ways for treating RA by reducing synovial
hyperplasia [16].
As indicated by previous studies, flavonoids from plant
extracts could induce synoviocytes apoptosis and sup-
press proliferation of in AA rats [48] and induced apop-
tosis of fibroblast-like synovial cells in human RA [49].
Similarly, we found a pro-apoptotic effect of TFB on
synovial apoptosis in rats with AA in vivo. In a represen-
tative image of DNA agarose gel electrophoresis, forma-
tion of apoptotic DNA ladders was found in DNA
extracts of synovial tissues from TFB-treated groups.
TFB increased the number of TUNEL-positive cells in
the synovial tissues of AA rats. We also demonstrated
that TFB treatment in rats with AA might induce syn-
ovial apoptosis via up-regulation of caspase-3 activity.
From the study, extracts from from Bidens bipinnata L.
showed significant total flavonoids contents. Therefore,
further studies are needed to isolate pure compounds
from the crude extract and to better understand the
mechanism involved in the process of synovial apoptosis
in RA.
Conclusions
Our study showed that TFB has a remarkable protective
action against FCA-induced AA in rats. TFB can signifi-
cantly ameliorate disease severity as assessed by paw
swelling, the polyarthritis index and histologic evalu-
ation. The therapeutic effects of TFB against inflamma-
tion in AA rats were associated with its ability to induce
synovial apoptosis in vivo through modulation of
caspase-3 activation. Further work is needed to clarify
the detailed mechanisms of action of TFB at the molecu-
lar level.
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